| Identification | More | [Name]
2,3,4-Trifluoro-6-nitroaniline | [CAS]
148416-38-0 | [Synonyms]
2,3,4-TRIFLUORO-6-NITROANILINE
2-NITRO-4,5,6-TRIFLUOROANILINE
6-NITRO-2,3,4-TRIFLUOROANILINE
BUTTPARK 24\01-62
6-Nitro-2,3,4-trifluoroaniline 97%
6-Nitro-2,3,4-trifluoroaniline97%
2,3,4-TRIFLUORO-6-NITROANILINE 99% | [Molecular Formula]
C6H3F3N2O2 | [MDL Number]
MFCD00174089 | [Molecular Weight]
192.1 | [MOL File]
148416-38-0.mol |
| Chemical Properties | Back Directory | [Melting point ]
59-61 °C(lit.) | [Boiling point ]
287.6±35.0 °C(Predicted) | [density ]
1.653±0.06 g/cm3(Predicted) | [storage temp. ]
Keep in dark place,Inert atmosphere,Room temperature | [solubility ]
soluble in Methanol | [form ]
Powder | [pka]
-2.75±0.25(Predicted) | [color ]
White | [CAS DataBase Reference]
148416-38-0(CAS DataBase Reference) |
| Safety Data | Back Directory | [Hazard Codes ]
Xi,T,Xn | [Risk Statements ]
R36/37/38:Irritating to eyes, respiratory system and skin .
R20/21/22:Harmful by inhalation, in contact with skin and if swallowed . | [Safety Statements ]
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice .
S36:Wear suitable protective clothing .
S36/37/39:Wear suitable protective clothing, gloves and eye/face protection . | [WGK Germany ]
3
| [Hazard Note ]
Toxic | [HazardClass ]
TOXIC | [HS Code ]
29214200 |
| Hazard Information | Back Directory | [Chemical Properties]
White to yellow solid | [Synthesis]
The general procedure for the synthesis of 2,3,4-trifluoro-6-nitroaniline using N-(2,3,4-trifluorophenyl)acetamide as starting material was as follows: concentrated nitric acid (1.25 mL) was added slowly and dropwise to a solution of sulfuric acid (14 mL) of 2,3,4-trifluoroacetanilide (4.34 g) obtained from step 1 under ice bath conditions. The reaction mixture was maintained under stirring for 4 hours. Subsequently, crushed ice was added to the reaction mixture and the precipitated yellow solid was collected by filtration to afford 2,3,4-trifluoro-6-nitroaniline (1.56 g, 35% yield). The infrared spectrum (IR, cm?1, pure) of the product showed characteristic absorption peaks located at 3483, 3361, 1664, 1600, 1540, 1515. nuclear magnetic resonance hydrogen spectroscopy (1H NMR) data: δ 6.10 (broad single peak, D?O exchangeable, 2H), 7.80 (multiple peaks, 1H). Mass spectra (EI-MS) showed molecular ion peak m/z: 192 (M?), and fragment ion peaks m/z: 175, 119. | [References]
[1] Journal of Medicinal Chemistry, 1995, vol. 38, # 22, p. 4367 - 4379
[2] Patent: WO2004/37765, 2004, A1. Location in patent: Page 8
[3] Journal of Fluorine Chemistry, 2003, vol. 121, # 2, p. 171 - 175 |
|
|